However, based on the distinct mechanism of JA in stabilizing SF3B1, rather than inhibition as demonstrated by other spliceosome modulators, it is likely that JA might engage a novel mechanism to regulate the cancer spliceosome activities. The gene discussed is SF3B1; the disease is cancer.